Predicting the Progression of Very Early Systemic Sclerosis: Current Insights

By sjmartinez • September 15, 2022

Bellocchi C, Chung A, Volkmann ER. Predicting the Progression of Very Early Systemic Sclerosis: Current Insights. Open Access Rheumatol. 2022 Sep 15;14:171-186. doi: 10.2147/OARRR.S285409. PMID: 36133926; PMCID: PMC9484572.

Tags: disease progression, early diagnosis, Publications, Pulmonary, Critical Care & Sleep Medicine, Scleroderma, systemic sclerosis

Host targets of candidalysin

Lin J, Filler SG. Host targets of candidalysin. PLoS Pathog. 2025 Jun 23;21(6):e1013284. doi: 10.1371/journal.ppat.1013284. PMID: 40549807; PMCID: PMC12184922.

Chimneys

Reuben DB. Chimneys. JAMA Intern Med. 2025 Jun 23. doi: 10.1001/jamainternmed.2025.1822. Epub ahead of print. PMID: 40549397.

Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer

LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in[...]